Reduced rates of antimicrobial resistance in Staphylococcus intermedius group and Escherichia coli isolated from diseased companion animals in an animal hospital after restriction of antimicrobial use

The 2016 National Action Plan aims for reduction in antimicrobial resistance (AMR) to tetracyclines, third-generation cephalosporins, and fluoroquinolones in Escherichia coli isolates from livestock: to lower the tetracycline resistance of E. coli to 33% or less; to maintain the third-generation cep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019-07, Vol.25 (7), p.531-536
Hauptverfasser:	Kurita, Goro, Tsuyuki, Yuzo, Murata, Yoshiteru, Takahashi, Takashi
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - standards Anti-Bacterial Agents - therapeutic use Antimicrobial resistance Cats Companion animals Dogs Drug Resistance, Multiple, Bacterial - drug effects Escherichia coli Escherichia coli - isolation & purification Escherichia coli - physiology Escherichia coli Infections - drug therapy Escherichia coli Infections - microbiology Escherichia coli Infections - veterinary Hospitals, Animal - standards Hospitals, Animal - statistics & numerical data Japan Pets - microbiology Practice Guidelines as Topic Restriction of antimicrobial use Staphylococcal Infections - drug therapy Staphylococcal Infections - microbiology Staphylococcal Infections - veterinary Staphylococcus intermedius - isolation & purification Staphylococcus intermedius - physiology Staphylococcus intermedius group
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!